In most invasive cervical carcinomas, high-risk human papillomavirus (
HPV) DIVA is integrated into the host genome, while in pre-invasive ce
rvical lesions the viral genome is typically maintained exclusively as
an episome. In contrast, integration of low-risk HPV DIVA is rare, as
is the association of low-risk HPVs with carcinomas. High-risk HPV in
tegration is associated with a selective growth advantage of affected
cells, and hence, integration is likely to be an important genetic alt
eration contributing to cervical tumor progression. Expression of high
-risk, but not low-risk, HPV E6 or E7 proteins disrupts the p53-depend
ent G(1) arrest that cells normally display in response to DIVA damage
. Absence of this cell cycle checkpoint may predispose cells containin
g high-risk HPVs to genetic instability and to the accumulation of the
genetic alterations that appear to be required for HPV-associated cer
vical tumor progression. We hypothesized that integration of highrisk
HPV DNA into the host cell genome may be facilitated by E6- and/or E7-
mediated disruption of the normal DIVA damage response pathway. To tes
t this hypothesis, we assessed the integration frequency of a reporter
plasmid (pHyGal) in RKO cells expressing individual E6 or E7 genes of
either high-risk (HPV16) or low-risk (HPV6, HPV11) type viruses. Cell
s expressing HPV16 E6 or HPV16 E7 exhibited a significantly increased
frequency of pHyGal integration in comparison to RKO control cells or
cells expressing low-risk HPV E6 or E7. Thus, expression of high-risk,
but not low-risk, E6 and E7 proteins increases the frequency of forei
gn DNA integration into the host genome. These findings suggest that a
t least some of the difference in oncogenic potential observed between
high-risk and low-risk HPV types may be determined by the increased a
bility of high-risk HPVs to integrate into host DNA.